Chemoproteomics reveals berberine directly binds to PKM2 to inhibit the progression of colorectal cancer

MLA

Shi-Hai Yan, et al. “Chemoproteomics Reveals Berberine Directly Binds to PKM2 to Inhibit the Progression of Colorectal Cancer.” IScience, vol. 25, no. 8, Aug. 2022. EBSCOhost, https://doi.org/10.1016/j.isci.2022.104773.

APA

Shi-Hai Yan, Li-Mu Hu, Xue-Hui Hao, Jiang Liu, Xi-Ying Tan, Zhi-Rong Geng, Jing Ma, & Zhi-Lin Wang. (2022). Chemoproteomics reveals berberine directly binds to PKM2 to inhibit the progression of colorectal cancer. IScience, 25(8). https://doi.org/10.1016/j.isci.2022.104773

Chicago

Shi-Hai Yan, Li-Mu Hu, Xue-Hui Hao, Jiang Liu, Xi-Ying Tan, Zhi-Rong Geng, Jing Ma, and Zhi-Lin Wang. 2022. “Chemoproteomics Reveals Berberine Directly Binds to PKM2 to Inhibit the Progression of Colorectal Cancer.” IScience 25 (8). doi:10.1016/j.isci.2022.104773.